Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_430755054e0ba06b4dc5721212ce6ddd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdce8bde7f4c58c8bd4a8d448fb80022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_934336eebb33476fba1e08768222c91e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-721 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_868daa47ff45cb46d80ac0c48763ff37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92e48230cfec88a5f2d5ae5dec76c3b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ab78336179e87fc7f0e02d03255fa9 |
publicationDate |
2014-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8841422-B2 |
titleOfInvention |
Human androgen receptor alternative splice variants |
abstract |
The present invention relates to novel androgen receptor splice variants (AR3, AR4, AR4b, AR5 and AR8) and variants and fragments thereof which have a role in the progression of androgen independent prostate cancer. The invention further relates to compositions and methods which can be used to identify and treat prostate cancer based on these novel androgen receptor splice variants, as well as methods for screening agents which modulate the activity and/or expression of the androgen receptor splice variants. Vectors, host cells and recombinant methods for producing the same and transgenic animals are also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098896-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359395-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808472-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9439912-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018015958-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884067-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387216-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478453-B2 |
priorityDate |
2008-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |